Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

41.86
+3.298.53%
Post-market: 41.900.0684+0.16%19:59 EDT
Volume:4.73M
Turnover:195.75M
Market Cap:3.62B
PE:-9.27
High:42.36
Open:39.59
Low:39.59
Close:38.57
Loading ...
Feb 12, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 29, 2020

Major Issues Report

Current report, item 5.02
Jan 24, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jan 10, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 27, 2019

Major Issues Report

Current report, items 1.02, 5.02, and 9.01
Dec 16, 2019

Major Issues Report

Current report, items 1.01, 1.02, and 2.01
Nov 26, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 22, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 19, 2019

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Oct 28, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 28, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 30, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 29, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jul 29, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 29, 2019

Major Issues Report

Current report, items 2.02 and 9.01